[{"address1": "320 Hatch Drive", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "415-851-2410", "website": "https://www.notablelabs.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Scott Alan McPherson CFE, CPA, CVA", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 412890, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.6149, "open": 0.57, "dayLow": 0.55, "dayHigh": 0.5927, "regularMarketPreviousClose": 0.6149, "regularMarketOpen": 0.57, "regularMarketDayLow": 0.55, "regularMarketDayHigh": 0.5927, "forwardPE": -0.16, "volume": 28478, "regularMarketVolume": 28478, "averageVolume": 91880, "averageVolume10days": 36610, "averageDailyVolume10Day": 36610, "marketCap": 5502051, "fiftyTwoWeekLow": 0.452, "fiftyTwoWeekHigh": 10.08, "priceToSalesTrailing12Months": 17.578438, "fiftyDayAverage": 0.59688, "twoHundredDayAverage": 1.374115, "currency": "USD", "enterpriseValue": 3257049, "floatShares": 2065780, "sharesOutstanding": 9659500, "sharesShort": 537665, "sharesShortPriorMonth": 302998, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0557, "heldPercentInsiders": 0.32950002, "heldPercentInstitutions": 0.045689996, "shortRatio": 4.33, "shortPercentOfFloat": 0.0863, "bookValue": 0.744, "priceToBook": 0.7655914, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -10542000, "trailingEps": -1.09, "forwardEps": -3.56, "enterpriseToRevenue": 10.406, "enterpriseToEbitda": -0.215, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NTBL", "underlyingSymbol": "NTBL", "shortName": "Notable Labs, Ltd.", "longName": "Notable Labs, Ltd.", "firstTradeDateEpochUtc": 1412170200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9e25d101-7671-335a-b328-0a6fce687c00", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.5696, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 4092000, "totalCashPerShare": 0.424, "ebitda": -15116000, "totalDebt": 1847000, "quickRatio": 1.699, "currentRatio": 2.775, "totalRevenue": 313000, "debtToEquity": 25.703, "revenuePerShare": 0.042, "returnOnAssets": -1.06094, "freeCashflow": -11457250, "operatingCashflow": -15154000, "grossMargins": 0.37061, "operatingMargins": -2690.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]